Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
WASHINGTON- – As opposition in Congress mounts to the White House’s decision to retain Ogilvy & Mather on its anti-drug media campaign, at least one of the losing contenders is considering filing a protest.
“We are trying to find out what is involved, what are the legalities and how to do this,” said one executive.
The protest will likely be filed after the White House Office of National Drug Control Policy debriefs the losing bidders this week about how the decision was reached, sources said.
Sources
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in